Showing results (51-60 of 599) with videos related to
Sort By:
Pageof 60
Health Affairs (Project Hope)|January 9, 2008
Market-based licensing for HPV vaccines in developing countriesKevin Outterson, Aaron S KesselheimThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 6, 2015
What Will It Take to Address the Global Threat of Antibiotic Resistance?Steven J Hoffman, Kevin OuttersonJournal of Managed Care & Specialty Pharmacy|September 27, 2019
A Strategy to Support Efficient Development and Use of Innovations in Personalized Medicine and Precision MedicineLouis P Garrison, Adrian TowseThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Genetic screening, health care and the insurance industry. Should genetic information be made available to insurers?Diego F Ossa, Adrian TowsePharmacoeconomics|January 21, 2010
Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical productsAdrian Towse, Louis P GarrisonValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Economic incentives for evidence generation: promoting an efficient path to personalized medicineAdrian Towse, Louis P GarrisonSocial Science & Medicine (1982)|September 11, 2017
Crowdfunding our health: Economic risks and benefitsMatthew J Renwick, Elias MossialosThe Health Service Journal|August 9, 2018
Five reasons why the NHS is better in the EULord Ara Darzi, Elias MossialosHealth Affairs (Project Hope)|August 1, 2009
How Medicare could get better prices on prescription drugsKevin Outterson, Aaron S KesselheimInternational Journal of Health Care Finance and Economics|November 25, 2003
Differential pricing for pharmaceuticals: reconciling access, R&D and patentsPatricia M Danzon, Adrian TowsePageof 60